Correlation Between Nuvalent and Verrica Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Nuvalent and Verrica Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nuvalent and Verrica Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nuvalent and Verrica Pharmaceuticals, you can compare the effects of market volatilities on Nuvalent and Verrica Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nuvalent with a short position of Verrica Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nuvalent and Verrica Pharmaceuticals.
Diversification Opportunities for Nuvalent and Verrica Pharmaceuticals
-0.2 | Correlation Coefficient |
Good diversification
The 3 months correlation between Nuvalent and Verrica is -0.2. Overlapping area represents the amount of risk that can be diversified away by holding Nuvalent and Verrica Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Verrica Pharmaceuticals and Nuvalent is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nuvalent are associated (or correlated) with Verrica Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Verrica Pharmaceuticals has no effect on the direction of Nuvalent i.e., Nuvalent and Verrica Pharmaceuticals go up and down completely randomly.
Pair Corralation between Nuvalent and Verrica Pharmaceuticals
Given the investment horizon of 90 days Nuvalent is expected to generate 0.14 times more return on investment than Verrica Pharmaceuticals. However, Nuvalent is 7.01 times less risky than Verrica Pharmaceuticals. It trades about 0.18 of its potential returns per unit of risk. Verrica Pharmaceuticals is currently generating about -0.02 per unit of risk. If you would invest 9,024 in Nuvalent on August 31, 2024 and sell it today you would earn a total of 652.00 from holding Nuvalent or generate 7.23% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Nuvalent vs. Verrica Pharmaceuticals
Performance |
| Timeline |
| Nuvalent |
| Verrica Pharmaceuticals |
Nuvalent and Verrica Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Nuvalent and Verrica Pharmaceuticals
The main advantage of trading using opposite Nuvalent and Verrica Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nuvalent position performs unexpectedly, Verrica Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Verrica Pharmaceuticals will offset losses from the drop in Verrica Pharmaceuticals' long position.| Nuvalent vs. Arcellx | Nuvalent vs. Vaxcyte | Nuvalent vs. Viridian Therapeutics | Nuvalent vs. Ventyx Biosciences |
| Verrica Pharmaceuticals vs. Cue Biopharma | Verrica Pharmaceuticals vs. Tff Pharmaceuticals | Verrica Pharmaceuticals vs. Eliem Therapeutics | Verrica Pharmaceuticals vs. Inhibrx |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |